Latest posts tagged with #LCSM on Bluesky
📣 England fans: Win 2 tickets to England vs Uruguay at Wembley on 27 March.
£5 to enter and every penny supports life-saving #lungcancer research.
Thank you to everyone who has already entered. 🩵
Enter 👇
raffall.com/415661/enter-r…
#lcsm #raffle #research
A new targeted drug called HS-20093 shrank tumours in just over 1/2 of people in the ARTEMIS-001 trial with extensive-stage small cell #lungcancer.
Still early, but this is another sign that new treatment options may finally be starting to open up in SCLC. #LCSM
www.cell.com/cancer-cell/...
The phase 3 TACTI-004 trial has been discontinued in patients with NSCLC in accordance with an independent data monitoring committee recommendation. #oncology #lcsm #nsclc
Read more here: www.onclive.com/view/tacti-0...
🆕 real-world data from Brazil adds to the case for broad biomarker testing in non-squamous NSCLC.
NRG1 fusions found in 0.8% cases when DNA & RNA sequencing were used together. For rare but actionable alterations, how you test matters.
www.lungcancerjournal.info/article/S016... #LCSM #LungCancer
Safety evaluation of selective RET inhibitors in patients with #lungcancer: a real-world #pharmacovigilance study👥
t.co/Leaz1RbN1Y
#lcsm
Severe COVID-19 may be associated with an increased subsequent risk of #lungcancer.
A 🆕 study published in Cancer Cell suggests that severe respiratory viral infections can leave lasting changes in the lung environment that may accelerate tumour growth.
🔗 www.cell.com/cell/abstrac... #LCSM
‼️ Lung Cancer Europe News is now live.
A 🆕 multilingual platform bringing together reliable updates on #lungcancer research, policy and advocacy across Europe.
Read news from across our network & from member organisations, & share member updates from your country. #LCSM
🌐 lungcancereuropenews.eu
Researchers at Dana-Farber Cancer Institute show why SCLC stays out of reach of the immune system, even when cancer cells are vulnerable to immune attack. @danafarber.bsky.social #lcsm #oncology
www.onclive.com/view/when-sm...
www.tiktok.com/t/ZP843EVBj/
#LungCancer is a lady killer. Not all cancer is pink. Tell someone you love today. #cancer #lcsm
Between diagnosis, staging, and treatment planning, pulmonologists play a key role in lung cancer management. Jasleen Pannu, MBBS, of Ohio State University Wexner Medical Center, explains how these specialists fit into the multidisciplinary equation #lcsm #oncology www.onclive.com/view/the-fro...
Repeat chest infections can be an overlooked sign of #lungcancer.
Prof Robert Rintoul says slow clearing or repeat chest infections, should raise concern.
Finding lung cancer early is key to better outcomes, so awareness of less obvious symptoms is key. #LCSM
www.telegraph.co.uk/health-fitne...
Lung cancer is the biggest cancer killer of women in Europe yet is rarely recognised as a women’s health issue.
More women are being diagnosed across Europe, & in some countries deaths are still rising.
When we talk about women’s health, #lungcancer must be included.
#InternationalWomensDay #LCSM
Logo for STARS program
Are you a person who has/had lung cancer (or caregiver for same), and an active patient advocate interested in providing a lung cancer patient perspective to research? Apply to one of the IASLC STARS programs!
www.iaslc-stars.org/stars-program
Applications close March 12, 2026 #LCSM
Call for Expressions of Interest for Clinical Oncology and Surgery Representation on the BTOG Steering Committee:
Learn more: https://www.btog.org/join-the-btog-steering-committee/
Deadline for submission of expression of interest is Monday 9th March 2026.
#LCSM #LungCancer
We were pleased to join fellow advocates, clinicians and researchers at #BTOG26.
Multidisciplinary conversations like these matter — bringing the thoracic community together to keep pushing progress in #lungcancer.
#LCSM #StrongerTogether
At @btog.bsky.social 2026 clinicians shared real world experience managing side effects from lorlatinib in ALK+ #lungcancer.
As people stay on targeted therapy for years, practical strategies like dose adjustment and careful monitoring are becoming central to long term care. #LCSM
Day 2 at #BTOG26.
ALK Positive UK is in Edinburgh alongside EGFR+ UK & the Ruth Strauss Foundation.
A packed programme of #lungcancer science, trials & debate plus an important chance for charities to connect directly with the clinicians & researchers influencing care.
#LCSM
Today at an online event hosted by the European Lung Foundation, Anna Keuchenius, AI & Community Insights Lead at Lung Cancer Europe, spoke about AI in #lungcancer care.
Her message: AI should support people not overwhelm them with disconnected apps and platforms.
#AIinHealth #LCSM
At @btog.bsky.social 2026 we’re sharing an evaluation of the See Through the Symptoms #lungcancer awareness campaign.
It was developed by jointly by ALK+ UK, EGFR+ UK & the Ruth Strauss Foundation to encourage HCPs to consider lung cancer in people with persistent or unexplained symptoms. #LCSM
New NCCN Guidelines for #NSCLC emphasize integrated staging and molecular testing. Molecular analysis is mandatory for all nonsquamous NSCLC cases to guide targeted therapy.
Read the review: https://bit.ly/4b28ksw
#MedEd #OncTwitter #LungCancer #LCSM
Mark your calendars! The next chat takes place on April 7th during GLOBAL #AYACSM week!!!!
#AYACancerAwareness #BTSM #BCSM #LCSM #GYNCSM #ChildhoodCancer
[Happening tonight!!] We will be talking about social media tools in tonight's #ayacsm (adolescent and young adult cancer societal movement) @bsky.app chat!!
Part of another #OncSky community? ALL are welcome! #BTSM #BCSM #LCSM - let's keep building out communities!
We’ll be in Edinburgh this week for #BTOG26. Debra Montague, our Chair, will be there following the latest discussions in thoracic oncology.
For people living with ALK+ #lungcancer, the conversation around brain mets, resistance, treatment sequencing & access to next-line options is critical. #LCSM
Michaela Regan joins us as our EU Policy & Engagement Manager.
With 8 yrs experience in public affairs patient engagement, inclu work in #lungcancer, she brings strong insight to our European policy work.
Michaela will help strengthen advocacy & support more equitable care across Europe. #LCSM
Our March newsletter is out & for the first time, it’s multilingual.
We’ve also launched a new multilingual Lung Cancer Europe News website, with regular updates on #lungcancer policy, research & opportunities to get involved.
Read the newsletter 🔗 eepurl.com/jAC3HE #LCSM
⏰ This week!
We’re looking forward to welcoming you to #BTOG26 for world-class science, debate and collaboration in thoracic oncology.
🔗 https://www.btog.org/24th-btog-annual-conference-2026/
#LCSM #lungcancer
Pain assessment for patients with pulmonary nodules who underwent VATS needs to identify the patient’s pain trajectory category to better address their pain, which can improve their overall #qualityOfLife.
https://bit.ly/4rGnkDx
#LungCancer #LCSM #QoL
ALK+ #lungcancer often means staying on a TKI for years. If radiotherapy is needed for brain metastases or a growing spot, the big question is whether to continue the drug.
New ESMO–ESTRO guidance says combining them can increase side effects. #LCSM
www.sciencedirect.com/science/arti...
3.5M people in the UK are living with a rare disease. ALK+ #lungcancer is one of them.
On #RareDiseaseDay, we stand with everyone living with ALK+ & with the wider rare disease community calling for earlier diagnosis, equitable access to testing & treatment, & consistent specialist care. #LCSM
